FOUNDAYO

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0002-4953
  • Package NDC 0002-4953-31
  • Application number NDA220934
  • SPL ID ebe44919-a00d-4ea1-a511-18e6a87da34c
  • SPL set ID 8ac446c5-feba-474f-a103-23facb9b5c62
  • UNII VI5M9OZV2X
  • RxCUI 2739844
  • RxCUI 2739850
  • RxCUI 2739852
  • RxCUI 2739854
  • RxCUI 2739856
  • RxCUI 2739858
  • RxCUI 2739860
  • RxCUI 2739862
  • RxCUI 2739864
  • RxCUI 2739866
  • RxCUI 2739868
  • RxCUI 2739870

What the source publishes

Labeler
Eli Lilly and Company
Active ingredients
orforglipron
Form
TABLET, FILM COATED
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0002-4953_ebe44919-a00d-4ea1-a511-18e6a87da34c
{
  "name": "FOUNDAYO",
  "splId": "ebe44919-a00d-4ea1-a511-18e6a87da34c",
  "labels": [
    {
      "setId": "8ac446c5-feba-474f-a103-23facb9b5c62",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8ac446c5-feba-474f-a103-23facb9b5c62",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=8ac446c5-feba-474f-a103-23facb9b5c62"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Eli Lilly and Company",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE in 1 CARTON (0002-4953-31)  / 30 TABLET, FILM COATED in 1 BOTTLE (0002-4953-01)",
      "package_ndc": "0002-4953-31",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20260401"
    }
  ],
  "productId": "0002-4953_ebe44919-a00d-4ea1-a511-18e6a87da34c",
  "useDomain": "unknown",
  "dosageForm": "TABLET, FILM COATED",
  "productNdc": "0002-4953",
  "deaSchedule": null,
  "genericName": "orforglipron",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "ORFORGLIPRON CALCIUM",
      "strength": "17.2 mg/1"
    }
  ],
  "applicationNumber": "NDA220934",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20260401",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "VI5M9OZV2X"
    ],
    "rxcui": [
      "2739844",
      "2739850",
      "2739852",
      "2739854",
      "2739856",
      "2739858",
      "2739860",
      "2739862",
      "2739864",
      "2739866",
      "2739868",
      "2739870"
    ],
    "spl_set_id": [
      "8ac446c5-feba-474f-a103-23facb9b5c62"
    ],
    "manufacturer_name": [
      "Eli Lilly and Company"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0002-4953_ebe44919-a00d-4ea1-a511-18e6a87da34c"